Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-01-31 4:01 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 96,360,443 38.3% | 11,555,166![]() (+13.63%) | View |
2022-10-07 4:42 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 84,805,277 40.7% | 2,983,114![]() (+3.65%) | View |
2021-11-24 4:01 pm Sale | 13D | AquaBounty Technologies, Inc. AQB | KIRK RANDAL J | 5,344,002 7.5% | -12,875,822![]() (-70.67%) | View |
2020-12-21 4:01 pm Sale | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 81,822,163 43.6% | -2,177,837![]() (-2.59%) | View |
2020-12-21 4:01 pm Sale | 13D | AquaBounty Technologies, Inc. AQB | KIRK RANDAL J | 18,219,824 33.1% | -34,088![]() (-0.19%) | View |
2020-10-08 5:28 pm Sale | 13D | Oragenics, Inc. OGEN | KIRK RANDAL J | 230,792 0.4% | -4,381,374![]() (-95.00%) | View |
2020-08-13 4:43 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 84,000,000 48.7% | 2,476,064![]() (+3.04%) | View |
2020-08-13 4:27 pm Purchase | 13D | AquaBounty Technologies, Inc. AQB | KIRK RANDAL J | 18,253,912 42.3% | 4,002,159![]() (+28.08%) | View |
2020-03-02 5:05 pm Purchase | 13D | Oragenics, Inc. OGEN | KIRK RANDAL J | 4,612,166 9.9% | 4,610,233![]() (+238501.45%) | View |
2020-02-18 4:01 pm Purchase | 13D | AquaBounty Technologies, Inc. AQB | KIRK RANDAL J | 14,251,753 44.6% | 5,175,000![]() (+57.01%) | View |
2020-02-04 4:59 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 81,523,936 48.2% | 81,523,936![]() (New Position) | View |
2020-01-06 4:01 pm Sale | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 0 0% | -74,378,292![]() (Position Closed) | View |
2019-11-05 4:53 pm Sale | 13D | Halozyme Therapeutics, Inc. HALO | KIRK RANDAL J | 7,046,385 4.8% | -3,497,856![]() (-33.17%) | View |
2019-10-31 07:47 am Unchanged | 13D | AquaBounty Technologies, Inc. AQB | KIRK RANDAL J | 9,076,753 42% | 0 (Unchanged) | View |
2019-09-17 4:33 pm Sale | 13D | Fibrocell Science, Inc. FCSC | KIRK RANDAL J | 0 0% | -10,994,686![]() (Position Closed) | View |
2019-07-03 4:01 pm Sale | 13D | Halozyme Therapeutics, Inc. HALO | KIRK RANDAL J | 10,544,241 7.2% | -1,567,633![]() (-12.94%) | View |
2019-06-10 5:24 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 74,378,292 46.1% | 2,198,939![]() (+3.05%) | View |
2019-06-07 5:10 pm Sale | 13D | Halozyme Therapeutics, Inc. HALO | KIRK RANDAL J | 12,111,874 8.3% | -1,980,897![]() (-14.06%) | View |
2019-05-24 7:35 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 72,179,353 44.8% | 1,739,471![]() (+2.47%) | View |
2019-05-15 5:30 pm Purchase | 13D | Precigen, Inc. PGEN | KIRK RANDAL J | 70,439,882 43.7% | 3,650,645![]() (+5.47%) | View |